SCHEMBL5559314

SCHEMBL5559314

Cc1cc(S(=O)(=O)Cl)c(C)cc1Cl.O=S(=O)(Cl)c1ccc(C(F)(F)F)cc1Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 8/20 0.48
TRPV4 Q9HBA0 1/20 0.42
HCRTR1 O43613 1/20 0.40
HCRTR2 O43614 1/20 0.40
ALDH1A1 P00352 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MEN1 O00255 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
ATM Q13315 1/20 0.39
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
GLA P06280 1/20 0.38
PDE2A O00408 2/20 0.38
CDK1 P06493 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNA2 P20248 1/20 0.37
CCND1 P24385 1/20 0.37
CDK2 P24941 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29907293 0.86 TRPV4 (0.53) MCL1TRPV4ALDH1A1L3MBTL1MEN1
SCHEMBL66378 0.86 TRPV4 (0.53) MCL1TRPV4ALDH1A1L3MBTL1MEN1
SCHEMBL25362679 0.83 MCL1 (0.51) MCL1TRPV4ALDH1A1L3MBTL1MEN1
SCHEMBL29707985 0.79 SOD1 (0.47) L3MBTL1MEN1TSHRKMT2ALMNA
SCHEMBL152556 0.79 SOD1 (0.47) L3MBTL1MEN1TSHRKMT2ALMNA
SCHEMBL3088227 0.78 MCL1 (0.49) MCL1TRPV4ALDH1A1L3MBTL1MEN1
SCHEMBL16770865 0.75 MCL1 (0.47) MCL1ALDH1A1L3MBTL1MEN1TSHR
SCHEMBL2001719 0.74 TRPV4 (0.50) TRPV4ALDH1A1L3MBTL1
SCHEMBL29683114 0.73 ALDH1A1 (0.59) MCL1TRPV4ALDH1A1L3MBTL1MEN1
SCHEMBL67766 0.73 ALDH1A1 (0.59) MCL1TRPV4ALDH1A1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1610753-A4 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC (US) 2007-07-04 EP disclosed
EP-1610753-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2006-01-04 EP disclosed
WO-2004073634-A2 PHENYLENEDIAMINE UROTENSIN-II RECEPTOR ANTAGONISTS AND CCR-9 ANTAGONISTS ENCYSIVE PHARMACEUTICALS INC. (US) 2004-09-02 WO disclosed